UNITY Biotechnology (UBX) Provides Pipeline and Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. AAPL
7. SPY
8. APLD
9. ORCL
10. USO

Go back to UNITY Biotechnology (UBX) Provides Pipeline and Business Updates

UNITY Biotechnology Provides Pipeline and Business Updates

February 25, 2020 6:00 AM EST

Phase 2 study of UBX0101 in patients with osteoarthritis has completed enrollment

Topline 12- and 24-week results now expected in 2H 2020

First patient dosed in phase 1b study to explore higher dose and repeat doses

First-in-human study initiation for ophthalmology program expected in 2H 2020

SAN FRANCISCO, Feb. 25, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today provided... More